Literature DB >> 8903404

Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes.

M E de Vera1, Y M Kim, H R Wong, Q Wang, T R Billiar, D A Geller.   

Abstract

During sepsis or inflammation, the liver expresses various protective phenotypes such as the acute phase response or the heat shock response (HSR). Inducible nitric oxide synthase (NOS2) is also expressed in the liver in these conditions and may protect the liver under some circumstances and promote injury in others. We have previously reported that the acute phase response and NOS2 expression are differentially regulated, though both can be expressed simultaneously. The HSR is known to prevent expression of other genes, but its effects on NOS2 expression in the liver is unknown. Therefore, we examined how the HSR influences NOS2 expression in primary rat hepatocytes. Sodium arsenite (Ars) or hyperthermia (43 degrees C) induced the synthesis of hsp72 messenger RNA (mRNA) and protein in hepatocytes, indicating activation of the HSR. In the absence of the HSR, combinations of interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and interferon gamma (IFN-gamma) stimulated high levels of NOS2 mRNA and nitric oxide (NO) synthesis. However, treatment with Ars or heat shock significantly attenuated cytokine-induced NOS2 mRNA and NO production. The addition of the nuclear factor kappaB (NF-kappaB) inhibitor pyrrolidine dithiocarbamate also inhibited NOS2 expression, suggesting a role for NF-kappaB in the cytokine induction of NOS2 in hepatocytes. Cytokines induced the appearance of an NF-kappaB complex as shown in gel retardation assays; however, induction of the HSR by Ars partially prevented cytokine-induced formation of this band while hyperthermia had a more complete inhibition. Furthermore, preinduction of the HSR prevented the activation of the NOS2 promoter construct in hepatocytes transfected with a 1.6 kilobase NOS2 promoter linked to luciferase. These findings show that NO production in stressed cells can be modulated by the HSR, possibly through repression of NOS2 gene transcription via the inhibition of NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903404     DOI: 10.1002/hep.510240542

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  6 in total

1.  Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages.

Authors:  Bruce J Grossman; Thomas P Shanley; Kelli Odoms; Katherine E Dunsmore; Alvin G Denenberg; Hector R Wong
Journal:  Inflammation       Date:  2002-06       Impact factor: 4.092

2.  Heat shock protein 72 overexpression prevents early postoperative memory decline after orthopedic surgery under general anesthesia in mice.

Authors:  Marcela P Vizcaychipi; Lijun Xu; George E Barreto; Daqing Ma; Mervyn Maze; Rona G Giffard
Journal:  Anesthesiology       Date:  2011-04       Impact factor: 7.892

3.  Stress response decreases NF-kappaB nuclear translocation and increases I-kappaBalpha expression in A549 cells.

Authors:  H R Wong; M Ryan; J R Wispé
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

Review 4.  Oxidative mechanism of arsenic toxicity and carcinogenesis.

Authors:  Honglian Shi; Xianglin Shi; Ke Jian Liu
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

5.  Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes.

Authors:  Shi-Qiang Shen; Yuan Zhang; Jin-Jian Xiang; Cheng-Long Xiong
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

6.  Short-term heat exposure inhibits inflammation by abrogating recruitment of and nuclear factor-{kappa}B activation in neutrophils exposed to chemotactic cytokines.

Authors:  Mira Choi; Birgit Salanova; Susanne Rolle; Maren Wellner; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  Am J Pathol       Date:  2008-01-10       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.